Axel Bolte

2019

In 2019, Axel Bolte earned a total compensation of $970.8K as President and Chief Executive Officer at Inozyme Pharma.

Compensation breakdown

Bonus$179,313
Option Awards$353,470
Salary$378,000
Other$60,000
Total$970,783

Bolte received $378K in salary, accounting for 39% of the total pay in 2019.

Bolte also received $179.3K in bonus, $353.5K in option awards and $60K in other compensation.

Rankings

In 2019, Axel Bolte's compensation ranked 9,401st out of 13,971 executives tracked by ExecPay. In other words, Bolte earned more than 32.7% of executives.

ClassificationRankingPercentile
All
9,401
out of 13,971
33rd
Division
Manufacturing
3,774
out of 5,701
34th
Major group
Chemicals And Allied Products
1,433
out of 2,200
35th
Industry group
Drugs
1,222
out of 1,886
35th
Industry
Pharmaceutical Preparations
909
out of 1,398
35th
Source: SEC filing on April 27, 2021.

Bolte's colleagues

We found one more compensation record of an executive who worked with Axel Bolte at Inozyme Pharma in 2019.

2019

Henric Bjarke

Inozyme Pharma

Chief Operating Officer

News

You may also like